AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Wiz acquires Dazz for $450 million to strengthen AI-driven cloud security
2
Cyera doubles valuation to $3B with $300M Series D, total funding hits $600M in seven months
3
Claroty veterans launch Twine with $12M in Seed funding from Dell and Wiz founders to deploy AI cyber workers
4
Mediaocean acquires Innovid for $500M, delisting it from the NYSE
5
Prompt Security raises $18 million Series A to protect enterprises from GenAI risks
More news

Cukierman

3 stories about Cukierman
Dr Laurent Choppe Managing Partner at Cukierman Co Life Sciences

Prepare for a year of M&As in Israeli life sciences companies

28.11.21|Laurent Choppe
Massive fund raising, significant growth in M&A deals and even a first Israeli biomed SPAC; Dr. Laurent Choppe, Managing Partner at Cukierman & Co. Life Sciences, explains the current trends behind the sector's amazing year and discusses what’s next
Dr Laurent Choppe Managing Partner at Cukierman Co Life Sciences

Israel third only to U.S. and China in Covid-19 solutions, says life sciences expert

17.07.20|Allon Sinai
"We don't talk anymore about devices or drugs. We talk about healthtech convergence, which for me is the future," explains Dr. Laurent Choppe, Managing Partner at Cukierman & Co. Life Sciences
אדוארד קוקירמן קטליסט

U.S.-China Trade War an Opportunity for Israeli Tech, Says Venture Capitalist

31.10.19|Lilach Baumer
Edouard Cukierman of Cukierman & Co. and Catalyst sees potential in the mounting trade tensions between the U.S. and China, and thinks Israeli companies should steer clear of Chinese politics